Front Row Advisors LLC Bio Rad Laboratories, Inc. Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 18 shares of BIO stock, worth $6,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 20
10.0%
Holding current value
$6,234
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$822 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$537 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$391 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$298 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$228 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.53B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...